Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BDC-2034
i
Other names:
BDC-2034
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Bolt Biotherap
Drug class:
CEACAM5-targeted antibody-drug conjugate, TLR8 agonist, TLR7 agonist
Related drugs:
‹
SAR408701 (12)
IMMU-130 (2)
EBC-129 (0)
M9140 (0)
imiquimod (4)
SBT6050 (4)
BDC-1001 (2)
SBT6290 (1)
VTX 2337 (1)
BDB018 (0)
CV8102 (0)
EIK1001 (0)
GQ1007 (0)
NKTR-262 (0)
imiquimod intravesical (0)
ZG0895 (0)
STM-416 (0)
TransCon TLR7/8 Agonist (0)
MEDI9197 (0)
AL-034 (0)
APR003 (0)
BNT411 (0)
LHC165 (0)
MBS8 (0)
RG6115 (0)
DSP-0509 (0)
SAR408701 (12)
IMMU-130 (2)
EBC-129 (0)
M9140 (0)
imiquimod (4)
SBT6050 (4)
BDC-1001 (2)
SBT6290 (1)
VTX 2337 (1)
BDB018 (0)
CV8102 (0)
EIK1001 (0)
GQ1007 (0)
NKTR-262 (0)
imiquimod intravesical (0)
ZG0895 (0)
STM-416 (0)
TransCon TLR7/8 Agonist (0)
MEDI9197 (0)
AL-034 (0)
APR003 (0)
BNT411 (0)
LHC165 (0)
MBS8 (0)
RG6115 (0)
DSP-0509 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CEACAM5 expression
Solid Tumor
CEACAM5 expression
Solid Tumor
BDC-2034
Sensitive: D – Preclinical
BDC-2034
Sensitive
:
D
BDC-2034
Sensitive: D – Preclinical
BDC-2034
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login